SG Americas Securities’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$585K Sell
16,293
-17,455
-52% -$452K ﹤0.01% 2094
2025
Q4
$671K Buy
33,748
+10,756
+47% +$207K ﹤0.01% 2316
2025
Q3
$420K Buy
+22,992
New +$378K ﹤0.01% 2244
2025
Q2
Sell
-21,334
Closed -$271K 3031
2025
Q1
$271K Buy
+21,334
New +$335K ﹤0.01% 2293
2015
Q1
Sell
-148,029
Closed -$3.32M 2589
2014
Q4
$3.32M Buy
148,029
+45,207
+44% +$1.18M 0.02% 768
2014
Q3
$2.82M Buy
+102,822
New +$3.11M 0.02% 739

Other funds holding CLMT

SG Americas Securities's CLMT Position: Q1 2026 in Review

SG Americas Securities reduced its Calumet Specialty Products (CLMT) stake by 52% in Q1 2026, selling an estimated $452K and leaving 16,293 shares worth $585K. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

SG Americas Securities first reported a position in CLMT in Q3 2014 and has held it in 6 quarters since. The position peaked at $3.32M in Q4 2014. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • SG Americas Securities held 16,293 shares of Calumet Specialty Products worth $585K as of Q1 2026.
  • SG Americas Securities sold 17,455 Calumet Specialty Products shares in Q1 2026, an estimated $452K.
  • Calumet Specialty Products made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2094 holding.
  • SG Americas Securities first reported a position in Calumet Specialty Products in Q3 2014 and has held it in 6 quarters since.
  • SG Americas Securities's Calumet Specialty Products position peaked at $3.32M in Q4 2014.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.